A rapid diagnostic test to detect multiple resistance determinants against the important carbapenem antibiotics

In 2050, the number of people dying as a result of infection with antibiotic-resistant bacteria could rise to ten million, according to WHO forecasts. For targeted therapies and to prevent the spread of antibiotic resistance, rapid and accurate diagnosis of resistance is essential. A new rapid test developed by DZIF researchers in cooperation with the company Coris BioConcept now makes it possible to detect over 95 percent of carbapenem resistance in patients infected with the widespread pathogenic bacterium Acinetobacter baumannii.

Quelle: IDW Informationsdienst Wissenschaft